<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01228929</url>
  </required_header>
  <id_info>
    <org_study_id>32315</org_study_id>
    <nct_id>NCT01228929</nct_id>
  </id_info>
  <brief_title>Non-invasive Ocular Surface Measurements Before and After Interventions</brief_title>
  <official_title>Non-invasive Ocular Surface Measurements Before and After Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objectively evaluate the ocular surface (pre-corneal tear film) of individuals prior to and
      after an intervention (such as a dry eye treatment, environmental change, artificial tear
      use, or contact lens wear) in a controlled-environmental chamber, over time using non-contact
      instruments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Most studies will set the environmental conditions (temperature, humidity, airflow) to mimic
      typical office and home environments (68 to 72F and 20 to 50%). For condition change studies,
      the chamber will operate between 65 and 85F and 25% and 80% RH with air flow turned off or
      set to a maximum of 3-4 m/s. For this type of study we will have the subject acclimate to a
      set of environmental conditions (approximately 20 minutes) and take a set of measurements.
      Then we will change the conditions (rate of change is 3F/hour and 3% RH/hour), have the
      subject acclimate to these conditions (later on the same day or on another day) and take
      another set of measurements. The expected study length is approximately two hours for a
      single visit.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The study was terminated.
  </why_stopped>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Ocular Surface Temperature (OST)</measure>
    <time_frame>baseline and 30 minutes</time_frame>
    <description>Objectively evaluate the ocular surface temperature prior to and after 30 minutes of acclimation to three different environmental conditions in a controlled-environmental chamber using thermal imaging. 10 eyes were analyzed for each group.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Dry Eye Syndrome</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with no clinical diagnosis or symptoms of dry eye.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aqueous Deficiency Dry Eye (ADDE)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with low tear volume measured by Schirmer's test less than 10 mm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Meibomian Gland Dysfunction (MGD)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects having mild to moderate Meibomian Gland Dysfunction by slit lamp evaluation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Environmental Chamber Condition Change Intervention</intervention_name>
    <description>For condition change studies, the chamber will operate between 65 and 85 degrees F and 25% and 80% RH with air flow turned off or set to a maximum of 3-4 m/s. For this type of study, we will have the subject acclimate to a set of environmental conditions (approximately 20-30 minutes) and take a set of measurements. Then we will change the conditions (rate of change is 3 degrees F/hour and 3% RH/hour), have the subject acclimate to these conditions (later on the same day or on another day) and take another set of measurements. The expected study length is approximately two hours for a single visit. Subjects may be asked to return for additional visits to accommodate a variety of chamber conditions (temp, humidity, airflow) within the prescribed limits above.</description>
    <arm_group_label>Normal</arm_group_label>
    <arm_group_label>Aqueous Deficiency Dry Eye (ADDE)</arm_group_label>
    <arm_group_label>Meibomian Gland Dysfunction (MGD)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals with dry eye diagnoses (aqueous deficient dry eye [ADDE], and/or
             evaporative dry eye), dry eye symptoms (as associated with Sjogren's Syndrome
             diagnosis), refractive surgery, contact lens use, and exposure to dry work
             environments are appropriate to correlate clinical tests, subjective responses and
             objective measurements of current ocular surface status and to study
             clinically-recommended or patient-directed dry eye treatments such as taking dietary
             supplements, wearing moisture-retaining goggles, performing lid massage, or using over
             the counter eye drops or artificial tears.

          -  Individuals who do not currently have dry eye symptoms but who may be at risk for dry
             eye diagnosis, and those who have dry eye symptoms but no clinical dry eye diagnosis,
             are of interest to correlate clinical tests, subjective responses and objective
             measurements of current ocular surface status and, if symptoms appear or worsen, to
             correlate the data with the effect of environmental condition changes, such as
             increasing the humidity or reducing air flow, on the ocular surface.

          -  Individuals who have undergone ocular surgery are at increased risk for dry eye. While
             some subjects who have had ocular surgery may never develop dry eye symptoms because
             they have an adequate reserve of tear production, others may develop symptoms as a
             result of the disruption of the ocular surface, including the anatomy and nerves.
             Subjects who have had surgery or procedures and are no longer being provided with
             direct post-operative care may participate in the study. Routine follow-up post-
             operative care does not disqualify subjects from participation. Subjects who are
             receiving post-operative care must obtain approval of their clinician to participate
             in the study.

          -  Individuals who have eye conditions that affect the shape or condition of the cornea,
             such as individuals with keratoconus.

          -  Experienced contact lens wearers are appropriate for studies that use their own lenses
             (soft, rigid gas permeable [RGP], hard [PMMA]) or the same type of lens within the FDA
             approved modality (daily, continuous or extended wear) and replacement cycle (for
             example, daily, one week, one month, etc.) as described in the lens package insert
             and/or prescribed by their eye care provider to investigate ocular surface data
             before, during and after lens use.

          -  Normal individuals, those without a dry eye diagnosis, without dry eye symptoms or
             those who do not wear contacts to act as controls for the focus areas in the studies.

        Exclusion Criteria:

        Individuals with eye or medical condition(s) that contraindicate performing screening or
        measurements will not be eligible for this study. Specific examples include:

          -  Individuals will not be dilated if an exam and/or medical history indicted they have a
             narrow anterior chamber angle, glaucoma, or other contraindications to dilation (like
             arterio-sclerotic cerebrovascular disease).

          -  Individuals with the following will not participate in contact lens studies: presence
             of ocular or systemic allergies or disease (infection), clinically significant (grade
             3 or 4) corneal edema, corneal vascularization, or any other abnormalities of the
             cornea, tarsal abnormalities or bulbar injection or use of medication that might
             interfere with contact lens wear.

          -  Individuals will not participate in any aspect of the study if: they are pregnant or
             become pregnant or are lactating, have an infectious disease (e.g. hepatitis,
             tuberculosis) or have an immuno-suppressive disease (e.g. HIV).

          -  Individuals with known sensitivity to dyes or to numbing drops will not be screened
             using these agents.

          -  Individuals who wear dental braces cannot be involved in the measurements in which a
             dental impression/bite bar is required. The impression material will stick to the
             braces. Individuals with very sensitive teeth or loose dentures may have difficulty
             making the dental impression.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James V Aquavella, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Flaum Eye Institute at the University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2010</study_first_submitted>
  <study_first_submitted_qc>October 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2010</study_first_posted>
  <results_first_submitted>July 31, 2015</results_first_submitted>
  <results_first_submitted_qc>September 17, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 12, 2015</results_first_posted>
  <last_update_submitted>September 17, 2015</last_update_submitted>
  <last_update_submitted_qc>September 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>James V. Aquavella, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Dry Eye</keyword>
  <keyword>Non-invasive instruments</keyword>
  <keyword>MGD</keyword>
  <keyword>Environment</keyword>
  <keyword>Thermal Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Normal</title>
          <description>Subjects with no clinical diagnosis or symptoms of dry eye. Each participant completed 3 environmental conditions. Nominal is 75 degrees F and 40% relative humidity. Low humidity is 20% relative humidity and 75 degrees F. High temperature is 85 degrees F and 40% relative humidity.</description>
        </group>
        <group group_id="P2">
          <title>Aqueous Deficiency Dry Eye (ADDE)</title>
          <description>Subjects with low tear volume measured by Schirmer's test less than 10 mm. Each participant completed 3 environmental conditions. Nominal is 75 degrees F and 40% relative humidity. Low humidity is 20% relative humidity and 75 degrees F. High temperature is 85 degrees F and 40% relative humidity.</description>
        </group>
        <group group_id="P3">
          <title>Meibomian Gland Dysfunction (MGD)</title>
          <description>Subjects having mild to moderate Meibomian Gland Dysfunction by slit lamp evaluation. Each participant completed 3 environmental conditions. Nominal is 75 degrees F and 40% relative humidity. Low humidity is 20% relative humidity and 75 degrees F. High temperature is 85 degrees F and 40% relative humidity.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Nominal Condition</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Low Humidity Condition</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>High Temperature Condition</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Normal</title>
          <description>Subjects with no clinical diagnosis or symptoms of dry eye.</description>
        </group>
        <group group_id="B2">
          <title>Aqueous Deficiency Dry Eye (ADDE)</title>
          <description>Subjects with low tear volume measured by Schirmer's test less than 10 mm.</description>
        </group>
        <group group_id="B3">
          <title>Meibomian Gland Dysfunction (MGD)</title>
          <description>Subjects having mild to moderate Meibomian Gland Dysfunction by slit lamp evaluation.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="6"/>
            <count group_id="B4" value="18"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Ocular Surface Temperature (OST)</title>
        <description>Objectively evaluate the ocular surface temperature prior to and after 30 minutes of acclimation to three different environmental conditions in a controlled-environmental chamber using thermal imaging. 10 eyes were analyzed for each group.</description>
        <time_frame>baseline and 30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal</title>
            <description>Subjects with no clinical diagnosis or symptoms of dry eye.</description>
          </group>
          <group group_id="O2">
            <title>Aqueous Deficiency Dry Eye (ADDE)</title>
            <description>Subjects with low tear volume measured by Schirmer's test less than 10 mm.</description>
          </group>
          <group group_id="O3">
            <title>Meibomian Gland Dysfunction (MGD)</title>
            <description>Subjects having mild to moderate Meibomian Gland Dysfunction by slit lamp evaluation.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ocular Surface Temperature (OST)</title>
          <description>Objectively evaluate the ocular surface temperature prior to and after 30 minutes of acclimation to three different environmental conditions in a controlled-environmental chamber using thermal imaging. 10 eyes were analyzed for each group.</description>
          <units>degree celsius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="6"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nominal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.047" spread="0.03"/>
                    <measurement group_id="O2" value="0.020" spread="0.03"/>
                    <measurement group_id="O3" value="0.127" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Low humidity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.015" spread="0.02"/>
                    <measurement group_id="O2" value="0.062" spread="0.02"/>
                    <measurement group_id="O3" value="0.013" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>High temperature</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.060" spread="0.02"/>
                    <measurement group_id="O2" value="0.064" spread="0.02"/>
                    <measurement group_id="O3" value="-0.011" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Normal</title>
          <description>Subjects with no clinical diagnosis or symptoms of dry eye.</description>
        </group>
        <group group_id="E2">
          <title>Aqueous Deficiency Dry Eye (ADDE)</title>
          <description>Subjects with low tear volume measured by Schirmer's test less than 10 mm.</description>
        </group>
        <group group_id="E3">
          <title>Meibomian Gland Dysfunction (MGD)</title>
          <description>Subjects having mild to moderate Meibomian Gland Dysfunction by slit lamp evaluation.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. James V. Aquavella</name_or_title>
      <organization>University of Rochester</organization>
      <phone>585-275-8944</phone>
      <email>james_aquavella@urmc.rochester.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

